Andrew Adey, Ph.D.
I plan to continue my focus on the development and implementation of novel strategies to investigate the epigenome with high precision. This includes single cell approaches to disambiguate epigenetic and transcriptional heterogeneity within populations of cells which is typically obscured by bulk preparation methods.
Mushui Dai, M.D., Ph.D.
Anna Dennis, M.S., C.G.C.
Melanie Gillingham, Ph.D., R.D.
Kelly Hamman, M.S., C.G.C.
Cary Harding, M.D.
Susan Hayflick, M.D.
Professor and Chair
Brain iron accumulates in many human neurodegenerative disorders, including Parkinson disease, Alzheimer disease, multiple sclerosis, and HIV encephalopathy. To investigate brain iron dyshomeostasis, we study a group of rare, single gene disorders, called Neurodegeneration with Brain Iron Accumulation (NBIA).
Kory Keller, M.S., C.G.C.
David Koeller, M.D.
Karen Kovak, M.S., C.G.C.
Ms. Kovak has been providing genetic counseling services at OHSU for over 30 years, in many areas of specialty. She has a special interest in Huntington disease, and facilitates a support group for this condition as well as seeing individuals and families with HD at OHSU.
Jessica Kushner, M.S., C.G.C.
Genetic counselors are masters level health care professionals trained to provide information and support to people who have, or may be at risk for, genetic disorders. As part of the OHSU clinical genetics team, Ms. Kushner provides genetic counseling services to children and adult patients with a wide variety of genetic conditions.
R. Michael Liskay, Ph.D.
Stephen R. Moore, Ph.D., FACMG
Robb Moses, M.D.
Hiroyuki Nakai, M.D., Ph.D.
The major focuses of our laboratory are the elucidation of the biology of recombinant adeno-associated virus (rAAV) vectors and cellular biology associated with rAAV infection/transduction, and development of new rAAV vector-mediated gene and cell therapies to treat various human diseases.
Susan Olson, Ph.D.
Brian J. O'Roak, Ph.D.
Our lab uses genomic approaches to unlock the genetic basis of neurodevelopmental disorders and related disorders, such as autism and intellectual disability. Our goal is to develop early interventions and biologically based personal therapies that can dramatically improve the lives of individuals affected with these disorders.
Carolyn Sue Richards, Ph.D., FACMG
The focus of my clinical research laboratory is development of sequence-based testing for rare disorders, development of custom analysis to address copy number variants, design of algorithms using analysis tools for interpretation of sequence variations and translation of these products into clinical practice.